New drug duo takes on hard-to-treat cancers
NCT ID NCT04896697
First seen May 10, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This early-stage study tests a new drug called vilastobart, alone or with another drug (atezolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and see if the drugs shrink tumors. About 136 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
California Cancer Associates for Research and Excellence, cCARE
Encinitas, California, 92024, United States
-
California Cancer Associates for Research and Excellence, cCARE
San Marcos, California, 92069, United States
-
Carolina BioOncology Institute
Huntersville, North Carolina, 28078, United States
-
City of Hope
Duarte, California, 91010, United States
-
City of Hope-Lennar
Irvine, California, 92618, United States
-
City of Hope-Upland
Upland, California, 91786, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Hospital
Rochester, Minnesota, 55905, United States
-
NEXT Virginia
Fairfax, Virginia, 22031, United States
-
Next Oncology
Austin, Texas, 78758, United States
-
Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, Florida, 32827, United States
-
Tranquil Clinical Research
Webster, Texas, 77598, United States
-
UCLA Hematology/Oncology- Santa Monica
Santa Monica, California, 90404, United States
-
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Pittsburgh Medical Center- Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.